Riskpilot← Back to searchSign inGet full accessDr Hedén AB
ABActiveOrg 5593038085Iversonsgatan 2Medical specialists activities · NACE 8622Est. 20210 employees
Revenue 2024
SEK 2,7M
-35% vs 2023
EBITDA margin
66.0%
-35% vs 2023
Equity ratio
12.4%
Financial strength
Net profit 2024
SEK 4,1M
+118% vs 2023
| Revenue | SEK 2,7M | -35% |
| EBITDA | SEK 1,8M | -35% |
| Net profit | SEK 4,1M | +118% |
| Total assets | SEK 93,2M | +5% |
| Equity | SEK 11,6M | +54% |
| Employees | 0 | — |
Legal name
Dr Hedén AB
Org number
5593038085
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
24 februari 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva plastikkirurgi och andra estetiska behandlingar, inom det medicinska området föreläsa och leda utbildning. Äga och förvalta fast och lös egendom och därmed förenlig verksamhet.
Address
Iversonsgatan 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 4 457 | 5 272 | 4 121 | 2 685 |
| Staff expenses | — | — | — | — |
| EBITDA | 1 123 | 2 043 | 2 710 | 1 772 |
| Depreciation & amort. | −0 | −7 | −5 | −11 |
| EBIT | 1 123 | 2 036 | 2 705 | 1 761 |
| Net financials | — | 1 066 | −49 461 | 3 295 |
| Profit before tax | 822 | 3 478 | −21 413 | 4 561 |
| Tax | −186 | −597 | −629 | −503 |
| Net profit | 636 | 2 881 | −22 042 | 4 058 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 104 952 | 110 051 | 88 440 | 93 180 |
| Equity | 661 | 29 579 | 7 537 | 11 595 |
| Long-term debt | 94 827 | 75 347 | 75 347 | 75 347 |
| Short-term debt | 9 163 | 1 867 | 2 361 | 2 547 |
| Total debt | 103 990 | 77 214 | 77 708 | 77 894 |
EBITDA margin
66.0%
This company
15.8%
Market median
+318% vs market
20212024
Equity ratio
12.4%
This company
38.2%
Market median
-68% vs market
20212024
Return on equity
35.0%
This company
18.4%
Market median
+90% vs market
20212024
Net profit margin
151.1%
This company
8.1%
Market median
+1765% vs market
20212024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20212024
Debt / equity
7.04×
This company
0.62×
Market median
-1035% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SJ Audit | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dr Hedén AB 
BTS Medical ABBoard members of Dr Hedén AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Johan Rendert | Audit | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Ebba Maria Helena Stark Hedén | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Per Göran Hedén | Board of Directors | 0 companies |